ARYA Atherosclerosis

Scope & Guideline

Unveiling groundbreaking insights in atherosclerosis research.

Introduction

Delve into the academic richness of ARYA Atherosclerosis with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1735-3955
PublisherISFAHAN UNIV MEDICAL SCIENCES, ISFAHAN CARDIOVASCULAR RES CENTER
Support Open AccessNo
CountryIran
TypeJournal
Converge2007, from 2011 to 2024
AbbreviationARYA ATHEROSCLER / ARYA Atheroscler.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 81465-1148, ISAFAHAN, REPUBLIC ISLAMIC 00000, IRAN

Aims and Scopes

ARYA Atherosclerosis focuses on advancing knowledge in cardiovascular health, disease prevention, diagnosis, and treatment methodologies. The journal encompasses a wide range of topics related to atherosclerosis and cardiovascular diseases, employing various research methodologies to address clinical and epidemiological questions.
  1. Cardiovascular Disease Epidemiology:
    Research in this area examines the prevalence, risk factors, and outcomes associated with cardiovascular diseases, utilizing systematic reviews and meta-analyses to synthesize data from various populations.
  2. Innovative Therapeutic Approaches:
    The journal publishes studies on novel treatments and interventions in cardiovascular care, including pharmacological trials and non-pharmacological strategies such as rehabilitation and lifestyle modifications.
  3. Diagnostic Techniques and Biomarkers:
    Focused on the development and validation of diagnostic tools and biomarkers for early detection and risk stratification in cardiovascular diseases, enhancing clinical decision-making.
  4. Interventional Cardiology:
    Research in this scope covers advancements in interventional techniques such as percutaneous coronary interventions and their outcomes, emphasizing procedural efficacy and patient safety.
  5. Clinical Guidelines and Practice Standards:
    The journal highlights the development of clinical practice guidelines and assessments of their implementation, aiming to improve cardiovascular care and patient outcomes.
  6. Impact of Comorbidities on Cardiovascular Health:
    Exploration of how comorbid conditions, such as diabetes and hypertension, influence cardiovascular disease progression and management strategies.
Recent publications in ARYA Atherosclerosis reflect evolving interests in emerging themes within cardiovascular research, showcasing a shift towards contemporary and relevant topics in the field.
  1. Impact of Lifestyle Factors on Cardiovascular Health:
    Increasing focus on how lifestyle modifications, such as exercise, diet, and smoking cessation, influence cardiovascular outcomes, reflecting a growing recognition of preventative care.
  2. Cardiovascular Effects of COVID-19:
    Emerging studies addressing the cardiovascular implications of COVID-19, including long-term effects on heart health and management strategies during the pandemic.
  3. Advanced Imaging Techniques:
    A trend towards utilizing advanced echocardiographic and imaging modalities to assess cardiac function and structure, underscoring the importance of precision medicine in cardiovascular diagnostics.
  4. Psychosocial Aspects of Cardiovascular Disease:
    Research investigating the psychological and social factors affecting cardiovascular patients, including mental health interventions and their impact on recovery and outcomes.
  5. Quality of Care and Healthcare Systems:
    An increasing emphasis on assessing the quality of cardiovascular care and the effectiveness of healthcare systems in managing cardiovascular diseases, aiming to enhance patient outcomes.

Declining or Waning

Despite the journal's robust focus on atherosclerosis and cardiovascular health, certain themes appear to be declining in prominence over the recent years. This section outlines those waning areas of research.
  1. Genetic Studies in Cardiovascular Disease:
    While genetic factors remain important in cardiovascular research, the frequency of publications focused specifically on genetic associations and polymorphisms has diminished, possibly due to a shift towards more clinical and intervention-focused studies.
  2. Traditional Risk Factor Assessments:
    There is a noticeable decrease in studies solely dedicated to traditional cardiovascular risk factors such as cholesterol levels and hypertension, indicating a broader focus on integrated approaches and novel risk factors.
  3. Historical Perspectives on Cardiovascular Interventions:
    Research examining historical approaches and long-term outcomes of older cardiovascular interventions appears to be waning, as the journal shifts towards contemporary practices and innovations.

Similar Journals

CURRENT CARDIOLOGY REVIEWS

Navigating the Future of Cardiology Together
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

Journal of the Practice of Cardiovascular Sciences

Innovating Solutions in Cardiovascular Health
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

Acta Cardiologica Sinica

Championing Excellence in Cardiovascular Research.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

Revista Portuguesa de Cardiologia

Empowering the fight against heart disease through open access research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

KARDIOLOGIYA

Cultivating a Legacy of Cardiac Research
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Nature Reviews Cardiology

Navigating the Complexities of Cardiovascular Health Together
Publisher: NATURE PORTFOLIOISSN: 1759-5002Frequency: 12 issues/year

Nature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.

Journal of Cardiology

Pioneering research to transform cardiology practices.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

HEART AND VESSELS

Pioneering Research in Heart Health and Vascular Function
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Cardiology in Review

Bridging research and practice in cardiology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

Journal of Cardiovascular Medicine

Exploring New Horizons in Cardiovascular Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.